Avantax Advisory Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,329
Closed -$254K 1593
2023
Q1
$254K Sell
2,329
-29
-1% -$3.17K ﹤0.01% 1245
2022
Q4
$268K Buy
+2,358
New +$268K ﹤0.01% 1163
2021
Q2
Sell
-4,763
Closed -$438K 1173
2021
Q1
$438K Buy
+4,763
New +$438K 0.01% 666
2020
Q4
Sell
-10,603
Closed -$824K 1414
2020
Q3
$824K Buy
+10,603
New +$824K 0.01% 598